Navigation Links
SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
Date:11/17/2011

/p>

A replay of the call will be available approximately two hours after the live call concludes through November 24, 2011. To access the replay, dial (888) 286-8010 (within the United States) or (617) 801-6888 (outside the United States). The passcode is 93812436. The webcast will also be archived on the Company's website.

About SeraCare Life Sciences, Inc.:SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics. The Company's innovative portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, biobanking and contract research services. SeraCare's quality systems, scientific expertise and state-of-the-art facilities support its customers in meeting the stringent requirements of the highly regulated life sciences industry.

Forward-Looking Statements:This press release contains disclosures that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about SeraCare Life Sciences, Inc. ("SeraCare" or the "Company"). All statements regarding our expected future financial position, results of operations, cash flows, dividends, financing plans, business strategy, budget, projected costs or cost savings, capital expenditures, competitive positions, growth opportunities for existing products or products under development, plans and objectives of management for future operations and markets for stock are forward-looking statements. In addition, forward-looking statements include statements in which we use words such as "expect," "believe," "anticipate," "intend," or similar expressions. Although we believe the expectations reflected in such forward-looking statements are based on reasonable assumptions, we cannot assure you that these expectations will prove to have been correct, and actual results may differ materially from those reflected in
'/>"/>

SOURCE SeraCare Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. SeraCare Life Sciences Secures $20 Million Credit Facilities
2. SeraCare Life Sciences to Report First Quarter 2011 Financial Results on February 11, 2011
3. SeraCare Reports First Quarter Fiscal Year 2011 Results
4. SeraCare Life Sciences Appoints Sean OConnor as Vice President of Sales and Marketing
5. SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors
6. SeraCare Reports Second Quarter Fiscal Year 2011 Financial Results
7. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
8. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
9. Par Pharmaceutical Reports Second Quarter 2008 Results
10. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
11. Pharmos Corporation Reports 2008 Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer ... infectious diseases, announced today that Jeffrey Riley , CEO, ... York Conference on Thursday, June 27, 2013 at The Metropolitan ... Riley is scheduled to present at 8:40 a.m. (Eastern Time). ... be accessed by logging onto the web at http://onemedplace.com/forum/webcast/ ...
(Date:6/19/2013)... --  NineSigma , Inc., of Cleveland ... NineSights.com is now the innovation engine for ... community of innovators. From technology developers, to ... stands out for its large community of innovators in ... all vetted by NineSigma. The community is free to ...
(Date:6/19/2013)... LOS ANGELES , June 19, 2013 Biotechnology ... is teaming up with financial software provider BlackLine Systems ... (NYSE: SAP ) for a webinar next week ... Amgen Uses Solutions from BlackLine and SAP to Help Keep ... (Logo: http://photos.prnewswire.com/prnh/20061117/LAF027LOGO ) The webinar, ...
(Date:6/19/2013)... 2013 India’s vast and growing ... be worth up to a billion dollars per ... government is taking serious action to better regulate ... This presentation will examine:, ,     Recent ...     Immediate and long term impacts ,     Foreseeable ...
Breaking Biology Technology:Synthetic Biologics to Present at OneMedForum New York 2013 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 2Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 4
... JERSEY CITY, New Jersey, October 29, Rosetta Genomics ... of microRNA-based diagnostics, announced today its,management will present ... 3-4, 2008 at the Waldorf-Astoria Hotel in New ... recently discovered, naturally occurring, small,RNAs that act as ...
... Inverness Medical,Innovations, Inc. (Amex: IMA ), a ... financial results for the quarter,ended September 30, 2008., ... net revenue of,$438.8 million compared to net revenue of ... increase was primarily due to $118.7 million,of incremental revenue ...
... Oct. 29 The Healthcare Scoop,( http://www.healthcarescoop.com ... patient stories about healthcare, will now extend ... organizations, according,to MaryAnn Stump, president, Consumer Aware. ... including Courage Center, Mayo,Clinic, The Emily Program, ...
Cached Biology Technology:Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 2Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 3Inverness Medical Innovations Announces Third Quarter 2008 Results 2Inverness Medical Innovations Announces Third Quarter 2008 Results 3Inverness Medical Innovations Announces Third Quarter 2008 Results 4Inverness Medical Innovations Announces Third Quarter 2008 Results 5Inverness Medical Innovations Announces Third Quarter 2008 Results 6Inverness Medical Innovations Announces Third Quarter 2008 Results 7Inverness Medical Innovations Announces Third Quarter 2008 Results 8Inverness Medical Innovations Announces Third Quarter 2008 Results 9Inverness Medical Innovations Announces Third Quarter 2008 Results 10Inverness Medical Innovations Announces Third Quarter 2008 Results 11Inverness Medical Innovations Announces Third Quarter 2008 Results 12Inverness Medical Innovations Announces Third Quarter 2008 Results 13Inverness Medical Innovations Announces Third Quarter 2008 Results 14Inverness Medical Innovations Announces Third Quarter 2008 Results 15Inverness Medical Innovations Announces Third Quarter 2008 Results 16Healthcare Scoop Expands Consumer Conversation to Dialogue with Premier Healthcare Organizations 2Healthcare Scoop Expands Consumer Conversation to Dialogue with Premier Healthcare Organizations 3
(Date:6/19/2013)... canary seeds bred specifically for human consumption qualifies as ... with celiac disease (CD), scientists have confirmed in a ... Food Chemistry . , Joyce Irene Boye and ... in the United States alone have CD. They develop ... and other grains that contain gluten-related proteins. Boye,s team ...
(Date:6/19/2013)... In fall 2012, the European Medicines Agency (EMA) ... the first ever gene therapy for clinical use ... company, had developed AAV-LPL S447X for the treatment ... lipase deficiency (LPLD) which affects approximately one or ... causes severe, life-threatening inflammations of the pancreas. Afflicted ...
(Date:6/18/2013)... awarded a $394,300 grant from the Tarrant Regional ... in the new facilities of the 150-mile Integrated ... professor of civil engineering, will investigate the best ... water in an effort to eliminate biological growths ... monochloramine is widely practiced throughout the United States. ...
Breaking Biology News(10 mins):No danger of cancer through gene therapy virus 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2
... of cardiac therapeutics have long looked to the future when ... one,s own heart cells. A study published in the February ... American Heart Association, shows that heart stem cells from children ... heart in an animal model. ...
... of Exeter has revealed that couples with similar personalities make ... least in the world of zebra finches. Researchers found ... a willingness to explore, did a much better job of ... were markedly different in personality, chicks didn,t fare as well ...
... For the first time, scientists have mapped the genome--the genetic ... efforts to maintain the genetic diversity of captive and wild ... be used to help improve our understanding of the evolution ... National Science Foundation, the orangutan study appears in the Jan. ...
Cached Biology News:Using a child's own stem cells to repair their heart looks promising 2Opposites may attract, but they don't make better parents 2Scientists determine what makes an orangutan an orangutan 2Scientists determine what makes an orangutan an orangutan 3
... MW 140kDa GenBank Accession ... spanning amino acids 926-941 (DKKVKPPFIPTIRGRE) of human ... Quality Assurance Routinely evaluated ... cells. Stability 1 year ...
Replacement Parts for Electrophoresis Apparatus...
Rabbit anti-phospho-EGFr (Tyr992) - Concentrate...
EMBP (FL-222)...
Biology Products: